Retraction

Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment

Paper Information

Record ID:

57867

Author(s):

Yoon-Jin Lee
Daniel L Karl
Ugwuji N Maduekwe
Courtney Rothrock
Sandra Ryeom
Patricia A D'Amore
Sam S Yoon

Journal:

Cancer Research ( American Association for Cancer Research )

Publication Date:

November 01, 2010

Retraction Date:

October 15, 2024 (1.1 year years ago)

Subjects:

Broad Categories:
Genetics Biology Biochemistry

Specific Fields:
Biochemistry Biology - Cancer Biology - Cellular Genetics

Institutions:

Country:

🇺🇸 United States

Article Type:

Research Article

Publisher:

American Association for Cancer Research

Open Access:

Yes

DOI:

10.1158/0008-5472.CAN-10-1138

PubMed ID:

20978198

Retraction PubMed ID:

39402992

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.1158/0008-5472.CAN-24-3248

Additional Notes:

see also: https://www.nytimes.com/2024/10/16/science/sam-yoon-columbia-cancer-surgeon-5-more-retractions.html

Citations (58)

58

Total Citations

1

Post-Retraction
(1.7%)

56

Pre-Retraction

1

Same Day

Post-Retraction Citation Analysis

1 Within 30 days

1 Within 1 year

0 After 2+ years

10 Days since retraction (latest)

Paper citing Differential Effects of VEGFR-1 and VEGFR-2 Inhibi...

Unknown Authors

Unknown Journal

Published: Oct 2024

10 days after retraction

Retraction: Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment

Yoon-Jin Lee, Daniel Karl, Ugwuji N. Maduekwe et al. (7 authors)

Cancer Research

Published: Oct 2024

Same day as retraction

Prolonged inhibition of intratumoral mast cells enhances efficacy of low‐dose antiangiogenic therapy

Nikolaus Berenbrok, María Elena Vargas-Delgado, Antonia Beitzen‐Heineke et al. (7 authors)

International Journal of Cancer Open Access

Published: Aug 2024
1 citation

54 days before retraction

Emerging therapies targeting growth factors in hepatocellular carcinoma

Samantha M. Ruff, Timothy M. Pawlik

Expert Opinion on Pharmacotherapy

Published: Feb 2024

247 days before retraction

Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with <scp>HCC</scp>

Jiwon Yang, Jonggi Choi, Won‐Mook Choi et al. (6 authors)

Liver International

Published: Jan 2024
2 citations

259 days before retraction

Anti‐angiogenesis in colorectal cancer therapy

Zhenni Yang, Xuqian Zhang, Xiaozhe Bai et al. (6 authors)

Cancer Science Open Access

Published: Jan 2024
16 citations

272 days before retraction

Molecularly Targeted Therapy for Gallbladder Cancer

Kyle C. Pierce, Christina Gomez

Unknown Journal

Published: Jan 2024

288 days before retraction

Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation

Hina Qayoom, Bader Alshehri, Burhan Ul Haq et al. (6 authors)

Saudi Journal of Biological Sciences Open Access

Published: Oct 2023
9 citations

360 days before retraction

Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids

Vinod K. Nelson, Mohana Vamsi Nuli, Juturu Mastanaiah et al. (20 authors)

Frontiers in Endocrinology Open Access

Published: Jul 2023
27 citations

448 days before retraction

The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis

Samantha M. Ruff, Alexander H. Shannon, Timothy M. Pawlik

Cancers Open Access

Published: Jul 2023
2 citations

467 days before retraction

Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) Using a Theoretical Model

Figueroa‐Valverde Lauro, Francisco Díaz-Cedillo, Rosas‐Nexticapa Marcela et al. (7 authors)

Drug Research

Published: May 2023
9 citations

522 days before retraction

Molecular Pathways in Gallbladder Cancer as Potential Therapeutic Target

Sameer Gupta, Puneet Prakash, Vijay Kumar et al. (5 authors)

Unknown Journal

Published: Jan 2023

653 days before retraction

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer

Giulia Dazio, Samantha Epistolio, Milo Frattini et al. (4 authors)

Journal of Clinical Medicine Open Access

Published: Dec 2022
6 citations

666 days before retraction

Dietary Diindolylmethane Enhances the Therapeutic Effect of Centchroman in Breast Cancer by Inhibiting Neoangiogenesis

Dhanamjai Penta, Jagadish Natesh, Priya Mondal et al. (4 authors)

Nutrition and Cancer

Published: Nov 2022
7 citations

703 days before retraction

Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade

Kelly N. Fitzgerald, Robert J. Motzer, Chung‐Han Lee

Nature Reviews Urology

Published: Nov 2022
25 citations

704 days before retraction

New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer

Xiang Zhu, Tingting Su, Shouhua Wang et al. (5 authors)

Frontiers in Oncology Open Access

Published: May 2022
19 citations

889 days before retraction

Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo

Tetsuo Mashima, Takeru Wakatsuki, Naomi Kawata et al. (10 authors)

Scientific Reports Open Access

Published: Jul 2021
12 citations

1180 days before retraction

Expresión inmunohistoquímica de VEGFR1 en carcinomas de pulmón de células no pequeñas: La expresión inferior de VEGFR1 se asocia con el subtipo de carcinoma de células escamosas y los valores elevados en SUVmáx en PET de 18F-FDG

M.C. Pombo Pasín, Virginia Pubul Núñez, L. García Bernardo et al. (6 authors)

Revista Española de Medicina Nuclear e Imagen Molecular

Published: May 2021

1250 days before retraction

Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study

Kinnosuke Matsumoto, Akihiro Tamiya, Yoshinobu Matsuda et al. (13 authors)

Translational Lung Cancer Research Open Access

Published: Apr 2021
15 citations

1293 days before retraction

Immunohistochemical expression of VEGFR1 in non small cell lung carcinomas: Lower VEGFR1 expression is asociated with squamous cell carcinoma subtype and high SUV max values in 18F-FDG PET

M.C. Pombo Pasín, Virginia Pubul Núñez, L. García Bernardo et al. (6 authors)

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Open Access

Published: Jan 2021
1 citation

1356 days before retraction

Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review)

Rehan Ahmad, J Singh, Amoolya Wunnava et al. (6 authors)

International Journal of Molecular Medicine Open Access

Published: Jan 2021
133 citations

1377 days before retraction

Molecular simulation studies to reveal the binding mechanisms of shikonin derivatives inhibiting VEGFR-2 kinase

Yeasmin Akter Munni, Md. Chayan Ali, Nusrat Jahan Selsi et al. (10 authors)

Computational Biology and Chemistry

Published: Nov 2020
16 citations

1440 days before retraction

Overview of current targeted therapy in gallbladder cancer

Xiaoling Song, Yunping Hu, Yongsheng Li et al. (6 authors)

Signal Transduction and Targeted Therapy Open Access

Published: Oct 2020
141 citations

1469 days before retraction

Comprehensive review of targeted therapy for colorectal cancer

Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang

Signal Transduction and Targeted Therapy Open Access

Published: Mar 2020
1370 citations

1670 days before retraction

Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models

Claudia Ceci, Maria Grazia Atzori, Pedro Miguel Lacal et al. (4 authors)

International Journal of Molecular Sciences Open Access

Published: Feb 2020
189 citations

1701 days before retraction

Host tissue determinants of tumour immunity

Hélène Salmon, Romain Remark, Sacha Gnjatic et al. (4 authors)

Nature reviews. Cancer Open Access

Published: Mar 2019
230 citations

2044 days before retraction

Targeting Fluorescent Nanodiamonds to Vascular Endothelial Growth Factor Receptors in Tumor

Marco D. Torelli, Ashlyn G. Rickard, Marina V. Backer et al. (9 authors)

Bioconjugate Chemistry Open Access

Published: Jan 2019
36 citations

2104 days before retraction

DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer

Sripathi M. Sureban, Randal May, Dongfeng Qu et al. (11 authors)

Vide Leaf, Hyderabad eBooks Open Access

Published: Jan 2019
7 citations

2114 days before retraction

Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations

Shailima Rampogu, Ayoung Baek, Amir Zeb et al. (4 authors)

BMC Cancer Open Access

Published: Mar 2018
56 citations

2414 days before retraction

Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation

Viola Lanier, Corey Gillespie, Merle Leffers et al. (11 authors)

The International Journal of Biochemistry & Cell Biology Open Access

Published: Sep 2016
41 citations

2963 days before retraction

Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants

Jan‐Philip Meyer, Kimberly J. Edwards, Paul Kozlowski et al. (6 authors)

Journal of Nuclear Medicine Open Access

Published: Jul 2016
28 citations

3022 days before retraction

Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines.

Mami Adachi, Yuki Hoshino, Yūsuke Izumi et al. (5 authors)

PubMed

Published: Jul 2016
11 citations

3028 days before retraction

New Insights in Vascular Lesions Development and Identification with Immunohistochemical Markers

Omar P. Sangüeza, Julio A. Díaz-Pérez

Springer eBooks

Published: Jan 2016
1 citation

3210 days before retraction

Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma

Mami Adachi, Yuki Hoshino, Yūsuke Izumi et al. (4 authors)

Journal of Veterinary Medical Science Open Access

Published: Dec 2015
10 citations

3222 days before retraction

Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model

Yuan Gu, Christina Körbel, Cláudia Scheuer et al. (6 authors)

Oncotarget Open Access

Published: Dec 2015
38 citations

3223 days before retraction

Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response toPlasmodium bergheiinfection and protect against experimental cerebral malaria

Miriam Canavese, Andrea Crisanti

Pathogens and Global Health Open Access

Published: Sep 2015
10 citations

3312 days before retraction

VEGF and LPS synergistically silence inflammatory response toPlasmodium bergheiinfection and protect against cerebral malaria

Miriam Canavese, Tania Dottorini, Andrea Crisanti

Pathogens and Global Health Open Access

Published: Sep 2015
12 citations

3312 days before retraction

sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways

Boh-Ram Kim, Seung Hee Seo, Mi Sun Park et al. (6 authors)

Oncotarget Open Access

Published: Sep 2015
29 citations

3323 days before retraction

Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo

Kazem Zibara, Zahraa Awada, Leila Dib et al. (8 authors)

Scientific Reports Open Access

Published: Jul 2015
85 citations

3367 days before retraction

AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis

Weidong Ji, Yonghao Li, Yun He et al. (8 authors)

Cancer Research Open Access

Published: Jul 2015
17 citations

3392 days before retraction

Expression and clinical significance of vascular endothelial growth factor and fms-related tyrosine kinase 1 in colorectal cancer

Linchun Wen, Rui Wang, Xiyan Lu et al. (4 authors)

Oncology Letters Open Access

Published: Jan 2015
9 citations

3575 days before retraction

Differential Antitumor Activity of Aflibercept and Bevacizumab in Patient-Derived Xenograft Models of Colorectal Cancer

Marielle Chiron, Rebecca G. Bagley, Jack Pollard et al. (9 authors)

Molecular Cancer Therapeutics Open Access

Published: Apr 2014
64 citations

3850 days before retraction

Angiogenic/osteogenic response of BMMSCs on bone‐derived scaffold: Effect of hypoxia and role of PI3K/Akt‐mediated VEGF‐VEGFR pathway

Yiting Zhou, Xiaoxu Guan, Mengfei Yu et al. (8 authors)

Biotechnology Journal

Published: Jan 2014
24 citations

3927 days before retraction

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept

Guido Giordano, Antonio Febbraro, Michele Venditti et al. (10 authors)

Gastroenterology Research and Practice Open Access

Published: Jan 2014
52 citations

3940 days before retraction

DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer

Sripathi M. Sureban, Randal May, Dongfeng Qu et al. (11 authors)

PLoS ONE Open Access

Published: Sep 2013
140 citations

4054 days before retraction

Paper citing Differential Effects of VEGFR-1 and VEGFR-2 Inhibi...

Unknown Authors

Unknown Journal

Published: Sep 2013

4062 days before retraction

Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway

Zhiyu Wang, Neng Wang, ShouWei Han et al. (10 authors)

PLoS ONE Open Access

Published: Jul 2013
210 citations

4120 days before retraction

4-Hydroxybenzyl alcohol: A novel inhibitor of tumor angiogenesis and growth

Matthias W. Laschke, Antonia E. Vorsterman van Oijen, Christina Körbel et al. (5 authors)

Life Sciences

Published: Jun 2013
20 citations

4152 days before retraction

Modulatory Role of VEGF in Angiogenesis for Cell Survival

Dipti Gatne, Veeranjaneyulu Addepalli, D.D. Santani

Springer eBooks

Published: Oct 2012
1 citation

4387 days before retraction

Stimulation of Host Bone Marrow Stromal Cells by Sympathetic Nerves Promotes Breast Cancer Bone Metastasis in Mice

James Campbell, Matthew R. Karolak, Yun Ma et al. (11 authors)

PLoS Biology Open Access

Published: Jul 2012
181 citations

4473 days before retraction

Quick Stats

Total Citations: 58

Years Since Retraction: 1.1 year

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice

Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment

Paper Information

Institutions:

Country:

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction Notice:

Additional Notes:

Citations (58)

58

1

56

1

Post-Retraction Citation Analysis

Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines.

Quick Stats

Related Papers

Actions